Glurenorm

repaglinide · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glurenorm, covering 2017-02-20 to 2017-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes [Phase 4]